Por qué algunos estados quieren garantizar Medicaid para los niños desde que nacen hasta los 6 años

Antes de que comenzara la emergencia de salud pública por covid-19 en 2020, millones de niños entraban y salían de Medicaid cada año, un indicio de que muchos perdían la cobertura por problemas administrativos, y no porque sus familias ganaran más y ya no fueran elegibles. Ahora, varios estados del oeste del país, como California, buscan cambiar esta situación con […]

Read more

Journalists Discuss Cracks in the Health Care System and Roadblocks to Covid Booster Shots

KHN senior correspondent Sarah Jane Tribble discussed her reporting for the podcast “Where It Hurts” on the “Too Long Didn’t Listen” podcast Feb. 3. Click here to hear Tribble on “Too Long Didn’t Listen“ Listen to “Where It Hurts“ KHN senior correspondent and enterprise reporter Liz Szabo discussed the problems immunocompromised people face in accessing a fourth covid-19 vaccine shot […]

Read more

Death in Dallas: One Family’s Experience in the Medicaid Gap

For years, Millicent McKinnon of Dallas went without health insurance. She was one of roughly 1 million Texans who earn too much to qualify for Medicaid in the state but too little to buy their own insurance. That is, until she died in 2019. She was 64 and had been unable to find consistent care for her breast cancer. Lorraine […]

Read more

Public Health Experts ‘Flabbergasted’ That Biden Still Hasn’t Picked an FDA Chief

President Joe Biden’s failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it’s baffling for the agency to be without a permanent leader during a national health crisis. The pandemic has taxed the FDA, an 18,000-person agency whose chiefs have traditionally received bipartisan backing […]

Read more

Health Care Unions Defending Newsom From Recall Will Want Single-Payer Payback

SACRAMENTO, Calif. — Should Gavin Newsom survive the Republican-driven attempt to oust him from office, the Democratic governor will face the prospect of paying back supporters who coalesced behind him. And the leaders of California’s single-payer movement will want their due. Publicly, union leaders say they’re standing beside Newsom because he has displayed political courage during the covid-19 pandemic by […]

Read more

Lo que debes saber sobre el refuerzo de la vacuna contra covid

La administración Biden anunció el miércoles 18 de agosto planes para ofrecer refuerzos de la vacuna contra covid-19 a todos los adultos estadounidenses a partir del próximo mes, y dijo que los datos recientes, incluidos algunos disponibles solo en los últimos días, jugaron un papel en esa decisión. “Si esperan a que suceda algo malo antes de responder, quedarán atrás”, […]

Read more

Have Vaccines, Will Travel: On the Road With a Covid Entrepreneur

VIRGINIA CITY, Mont. — While many businesses in this southwestern Montana “ghost town” reel in tourists with its mining and Wild West vigilante past, one businessman arrived offering a modern product: covid-19 vaccines. Kyle Austin, a traveling pharmacist, set up his mobile clinic in Virginia City on a recent Saturday, the latest stop on his circuit of Montana’s vaccine deserts. […]

Read more

FDA Approves Expanded Botox (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ — Allergan, an AbbVie (NYSE: ABBV) company, today announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion of Botox® to include eight new muscles for the treatment of upper limb spasticity in adults. The new muscles for treatment include additional muscles of the elbow and forearm (brachialis, brachioradialis, […]

Read more

FDA Approves Aduhelm

FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Aduhelm™ (aducanumab-avwa) as the first and only Alzheimer’s disease treatment to address a […]

Read more
1 2 3 15